Porocarcinoma: a rare cause of lateral cervical tumor

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Jul 20, 2019
DOI: https://doi.org/10.22551/2019.23.0602.10154
Gabriela Maria Aniței Nicolae Șerban Ioanid Geanina Bandol Elena Rodica Gafton Ana Maria Patrașcu Dan Ferariu Angelica Slătineanu Gema Bugean Viorel Scripcariu

Abstract

Porocarcinoma is a rare tumor of the eccrine sweat glands that usually disseminates to the regional lymph nodes, but it can also develop distant metastasis. Case presentation: We report the case of a 67 year-old female patient who underwent wide surgical resection of a left cervical cutaneous tumor in a primary care center, for which the histology exam of the specimen was mixed basal cell and squamous cell carcinoma. She was referred to our hospitals oncology clinic and histologic re-evaluation changed the diagnosis to eccrine porocarcinoma (EPC). Computer-tomography (CT) revealed cervical lymphadenopathies for which the patient underwent 4 cycles of chemotherapy, without regression. She subsequently underwent a left upper anterior jugular lymphadenectomy (group IIa) with all nodes being negative and, three months later, she developed a unique adenopathy under the parotid gland that was excised and confirmed to be metastatic. Postoperative external radiotherapy was administered with a good outcome on CT scan. Nine months after her last surgery, the patient did not show any sign of recurrence or distant metastasis. Conclusion: EPC is a challenge, both diagnostically and therapeutically. In the absence of consensus regarding the indications and extent of lymphadenectomy and adjuvant therapy, patients with EPC should be referred to an experienced multidisciplinary team in a tertiary center.

##plugins.themes.bootstrap3.article.details##

Keywords

eccrine porocarcinoma, skin cancer, sweat glands

References
1. Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms-part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol 2007; 60(2):129-144.
2. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms-part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol 2007; 60(2):145-159.
3. Oyasiji T, Tan W, Kane J, et al. Malignant adnexal tumors of the skin: a single institution experience. World J Surg Oncol 2018; 16(1):99.
4. Riera-Leal L, Guevara-Gutiérrez E, Barrientos-García JG, Madrigal-Kasem R, Briseño-Rodríguez G, Tlacuilo-Parra A. Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. Int J Dermatol 2015; 54(5):580-586.
5. Gutermuth J, Audring H, Voit C, Trefzer U, Haas N. Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatology Venereol 2004; 18(4):477-479.
6. De Iuliis F, Amoroso L, Taglieri L, et al. Chemotherapy of rare skin adnexal tumors: a review of literature. Anticancer Res 2014; 34(10):5263-5268.
7. Kurashige Y, Minemura T, Nagatani T. Eccrine porocarcinoma: clinical and pathological report of eight cases. Case Rep Dermatol 2013; 5:259-266.
8. Prieto-Granada C, Castner N, Chen A, et al. Behavior of cutaneous adnexal malignancies: a single institution experience. Pathol Oncol Res. 2018 [doi: 10.1007/s12253-018-0427-3].
9. Luz M de A, Ogata DC, Montenegro MFG, Biasi LJ, Ribeiro LC. Eccrine porocarcinoma (malignant eccrine poroma): a series of eight challenging cases. Clinics (Sao Paulo) 2010; 65(7):739-742.
10. Belin E, Ezzedine K, Stanislas S, et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 2011; 165(5):985-989.
11. Robson A, Greene J, Ansari N, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001; 25(6):710-720.
12. Marone U, Caracò C, Anniciello AM, et al. Metastatic eccrine porocarcinoma: report of a case and review of the literature. World J Surg Oncol 2011; 9:32.
13. Salih AM, Kakamad FH, Baba HO, et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg 2017; 20:74-79.
14. Stam H, van de Wiel BA, Klop WMC, et al. Skin adnexal carcinoma of the head and neck: a retrospective study in a tertiary referral center. Eur Arch Oto-Rhino-Laryngology 2015; 272(4):1001-1010.
15. Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: Clinical and pathological studies of 12 cases. J Dermatol 2007; 34(8):516-522.
16. Sahn RE, Lang PG. Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers. Dermatologic Surg 2007; 33(7):786-793.
17. Chang O, Elnawawi A, Rimpel B, Asarian A, Chaudhry N. Eccrine porocarcinoma of the lower extremity: A case report and review of literature. World J Surg Oncol 2011; 9:94.
18. Ramasenderan N, Shahir H, Omar SZ. A synchronous incidence of eccrine porocarcinoma of the forearm and facial squamous cell carcinoma: A case report. Int J Surg Case Rep 2018; 42:116-120.
19. Walsh MS. A case of eccrine porocarcinoma. J R Soc Med 1990; 83(8):529-530.
20. Orella Jal, Penalba Av, Juan Ccs, Nadal Rv, Morrondo Jc, Alvarez Tt. Eccrine porocarcinoma. Dermatologic Surg 1997; 23(10):925-928.
21. Barnes M, Hestley A, Murray DR, Carlson GW, Parker D, Delman KA. The risk of lymph node involvement in malignant cutaneous adnexal tumors. Am Surg 2014; 80(3):270-274.
22. Urso C, Bondi R, Paglierani M, Salvadori A, Anichini C, Giannini A. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med 2001; 125(4):498-505.
23. González-López MA, Vázquez-López F, Soler T, et al. Metastatic eccrine porocarcinoma: a 5.6-year follow-up study of a patient treated with a combined therapeutic protocol. Dermatol Surg 2003; 29(12):1227-1232.
24. Ponzetti A, Ribero S, Caliendo V, Spadi R, Macripò G, Lista P. Long-term survival after multidisciplinary management of a metastatic sarcomatoid porocarcinoma with repeated exeresis, radiotherapy, chemotherapy and cetuximab: case report and review of literature. G Ital Dermatol Venereol 2017; 152(1):66-70.
25. Fujimine-Sato A, Toyoshima M, Shigeta S, et al. Eccrine porocarcinoma of the vulva: a case report and review of the literature. J Med Case Rep 2016; 10(1):319.
26. Sawaya JL, Khachemoune A. Poroma: a review of eccrine, apocrine, and malignant forms. Int J Dermatol 2014; 53(9):1053-1061.
27. Barzi AS, Ruggeri S, Recchia F, Bertoldi I. Malignant metastatic eccrine poroma. Proposal for a new therapeutic protocol. Dermatol Surg 1997; 23(4):267-272.
How to Cite
Aniței, G. M., Ioanid, N. Șerban, Bandol, G., Gafton, E. R., Patrașcu, A. M., Ferariu, D., Slătineanu, A., Bugean, G., & Scripcariu, V. (2019). Porocarcinoma: a rare cause of lateral cervical tumor. Archive of Clinical Cases, 6(2), Arch Clin Cases 2019; 6(2):53-58. https://doi.org/10.22551/2019.23.0602.10154
Issue
Vol. 6 No. 2 (2019)
Section
Case Reports

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.

Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.

How to Cite

Aniței, G. M., Ioanid, N. Șerban, Bandol, G., Gafton, E. R., Patrașcu, A. M., Ferariu, D., Slătineanu, A., Bugean, G., & Scripcariu, V. (2019). Porocarcinoma: a rare cause of lateral cervical tumor. Archive of Clinical Cases, 6(2), Arch Clin Cases 2019; 6(2):53-58. https://doi.org/10.22551/2019.23.0602.10154